Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (393) 393
Publication (156) 156
Book / eBook (65) 65
Paper (53) 53
Newspaper Article (17) 17
Book Chapter (11) 11
Dissertation (8) 8
Conference Proceeding (5) 5
Magazine Article (5) 5
Report (3) 3
Book Review (1) 1
Patent (1) 1
Trade Publication Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (187) 187
index medicus (181) 181
female (142) 142
male (120) 120
article (82) 82
middle aged (72) 72
risk factors (69) 69
abridged index medicus (67) 67
adult (59) 59
pediatrics (56) 56
physics (55) 55
experiment (53) 53
particle physics (53) 53
mortality (49) 49
aged (48) 48
high energy physics - experiment (48) 48
infant, newborn (47) 47
health aspects (46) 46
physics - high energy physics - experiment (44) 44
infants (43) 43
research (41) 41
united states (36) 36
medical and health sciences (35) 35
medicin och hälsovetenskap (35) 35
analysis (34) 34
risk (34) 34
physics of elementary particles and fields (30) 30
high energy physics (29) 29
oncology (28) 28
particle physics - experiment (28) 28
animals (27) 27
infant (26) 26
clinical medicine (25) 25
treatment outcome (25) 25
aged, 80 and over (24) 24
studies (24) 24
breast cancer (23) 23
care and treatment (23) 23
cohort studies (23) 23
medicine, general & internal (23) 23
morbidity (23) 23
prevalence (23) 23
cancer (22) 22
epidemiology (22) 22
klinisk medicin (22) 22
age (21) 21
multidisciplinary sciences (21) 21
population (21) 21
polymorphism, single nucleotide (20) 20
research article (20) 20
risk-factors (20) 20
medical research (19) 19
breast neoplasms - genetics (18) 18
clinical trials (18) 18
medicine (18) 18
mice (18) 18
prospective studies (18) 18
adolescent (17) 17
case-control studies (17) 17
expression (17) 17
genetic aspects (17) 17
nuclear experiment (17) 17
outcomes (17) 17
regression analysis (17) 17
cardiovascular disease (16) 16
diabetes (16) 16
diagnosis (16) 16
genetics (16) 16
health sciences (16) 16
public health (16) 16
public, environmental & occupational health (16) 16
retrospective studies (16) 16
survival (16) 16
therapy (16) 16
trends (16) 16
children (15) 15
genome-wide association (15) 15
management (15) 15
mutation (15) 15
preterm infants (15) 15
young adult (15) 15
birth-weight infants (14) 14
cardiovascular diseases (14) 14
death (14) 14
disease (14) 14
electronic books (14) 14
genetic predisposition to disease (14) 14
genotype (14) 14
health risk assessment (14) 14
immunology (14) 14
phenomenology (14) 14
prevention (14) 14
socioeconomic factors (14) 14
age factors (13) 13
association (13) 13
elementary particles, quantum field theory (13) 13
hadron-hadron scattering (13) 13
history (13) 13
hälsovetenskaper (13) 13
infant mortality (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (38) 38
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UTL at Downsview - May be requested (8) 8
UofT at Mississauga - Stacks (8) 8
Gerstein Science - Stacks (7) 7
UofT at Scarborough - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
OISE - Stacks (5) 5
Architecture Landscape (Shore + Moffat) - Stacks (4) 4
Engineering & Comp. Sci. - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
New College (Ivey) - Stacks (2) 2
Royal Ontario Museum - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Trinity College (John W Graham) - Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Art - Oversize (1) 1
Baycrest Hospital - Wellness Library (1) 1
Criminology - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
OISE - Cancelled Order (1) 1
Robarts - Reference (1) 1
Royal Ontario Museum - Far Eastern (1) 1
Toronto East General Hospital - Stacks (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Missing (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. LAG-3 in cancer immunotherapy
by Goldberg, Monica V and Drake, Charles G
Current Topics in Microbiology and Immunology, ISSN 0070-217X, 2010, Volume 344, Issue 1, pp. 269 - 278
Checkpoint | Anergy | LAG-3 | Treg | Tumor immunology | Tolerance | CD8 lymphocyte | CD4 lymphocyte
Journal Article
Details down arrow
2. Full Text An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity
by Harris, Timothy J and Grosso, Joseph F and Yen, Hung-Rong and Xin, Hong and Kortylewski, Marcin and Albesiano, Emilia and Hipkiss, Edward L and Getnet, Derese and Goldberg, Monica V and Maris, Charles H and Housseau, Franck and Yu, Hua and Pardoll, Drew M and Drake, Charles G
Journal of Immunology, ISSN 0022-1767, 10/2007, Volume 179, Issue 7, pp. 4313 - 4317
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
by Overman, Michael J and McDermott, Ray and Leach, Joseph L and Lonardi, Sara and Lenz, Heinz-Josef and Morse, Michael A and Desai, Jayesh and Hill, Andrew and Axelson, Michael and Moss, Rebecca A and Goldberg, Monica V and Cao, Z Alexander and Ledeine, Jean-Marie and Maglinte, Gregory A and Kopetz, Scott and André, Thierry
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1182 - 1191
Metastatic DNA mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer has a poor prognosis after treatment with... 
CETUXIMAB | TAS-102 | HNPCC | ONCOLOGY | BRAF MUTATION | SAFETY | REGORAFENIB | RANDOMIZED-TRIAL | Carcinoma - drug therapy | Colorectal Neoplasms - mortality | Microsatellite Instability | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Antineoplastic Agents - therapeutic use | Disease-Free Survival | DNA Mismatch Repair | Nivolumab | Adult | Carcinoma - genetics | Female | Colorectal Neoplasms - pathology | Carcinoma - secondary | Care and treatment | Oncology, Experimental | DNA | Colorectal cancer | Genetic aspects | Metastasis | Research | Cancer | Chemotherapy | Analysis | Development and progression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text LAG-3 in Cancer Immunotherapy
by Goldberg, Monica V and Drake, Charles G
2011, Current Topics in Microbiology and Immunology, ISBN 9783642141355, Volume 344, 10
LAG-3 (CD223) is a cell surface molecule expressed on activated T cells (Huard et al. Immunogenetics 39:213–217, 1994), NK cells (Triebel et al. J Exp Med... 
Cancer Research | Biomedicine | Immunology | PROTEIN | Anergy | DENDRITIC CELLS | Treg | Tumor immunology | EFFECTOR FUNCTION | Tolerance | MICROBIOLOGY | IMMUNOLOGY | ANTITUMOR-ACTIVITY | Checkpoint | CD4 | LAG-3 | IMMUNE-RESPONSES | REGULATORY T-CELLS | CD8 lymphocyte | CD4 lymphocyte | LYMPHOCYTE-ACTIVATION GENE-3 | EXPRESSION | MHC CLASS-II | CD4-Positive T-Lymphocytes - immunology | Neoplasms - therapy | Animals | Humans | Immunotherapy | Antigens, CD - physiology | Antigens, CD - chemistry | CD8-Positive T-Lymphocytes - immunology
Book Chapter
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fc engineering approaches to enhance the agonism and effector functions of an Anti-OX40 antibody
by Zhang, Di and Goldberg, Monica V and Chiu, Mark L
Journal of Biological Chemistry, ISSN 0021-9258, 12/2016, Volume 291, Issue 53, pp. 27134 - 27146
Agonistic antibodies directed against immunostimulatory receptors belonging to the tumor necrosis factor receptor (TNFR) superfamily are emerging as promising... 
TNF RECEPTOR | OX40 | CELLS | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCLONAL-ANTIBODY | CANCER-IMMUNOTHERAPY | KAPPA-B | ANTITUMOR ACTIVITIES | TUMOR-IMMUNITY | GAMMA RECEPTOR ENGAGEMENT | Receptors, OX40 - agonists | Antibodies, Monoclonal - pharmacology | Humans | Cells, Cultured | Antibody-Dependent Cell Cytotoxicity - immunology | Receptors, IgG - metabolism | Receptors, OX40 - immunology | Antibodies, Monoclonal - genetics | Neoplasms - therapy | Receptors, IgG - genetics | Immunoglobulin Fc Fragments - immunology | Neoplasms - immunology | Immunotherapy | HEK293 Cells | Immunoglobulin Fc Fragments - pharmacology | Protein Engineering | Protein Binding | Macrophages - drug effects | Antibody-Dependent Cell Cytotoxicity - drug effects | Receptors, Tumor Necrosis Factor - immunology | Immunoglobulin Fc Fragments - genetics | Antibodies, Monoclonal - immunology | Macrophages - immunology | Immunoglobulin G - metabolism | antibody engineering | Molecular Bases of Disease | agonism | anticancer drug | tumor necrosis factor (TNF) | Fc receptor | immunotherapy | ADCC
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
by Woo, Seng-Ryong and Turnis, Meghan E and Goldberg, Monica V and Bankoti, Jaishree and Selby, Mark and Nirschl, Christopher J and Bettini, Matthew L and Gravano, David M and Vogel, Peter and Liu, Chih Long and Tangsombatvisit, Stephanie and Grosso, Joseph F and Netto, George and Smeltzer, Matthew P and Chaux, Alcides and Utz, Paul J and Workman, Creg J and Pardoll, Drew M and Korman, Alan J and Drake, Charles G and Vignali, Dario A. A
Cancer Research, ISSN 0008-5472, 02/2012, Volume 72, Issue 4, pp. 917 - 927
Inhibitory receptors on immune cells are pivotal regulators of immune escape in cancer. Among these inhibitory receptors, CTLA-4 (targeted clinically by... 
ACTIVATION | THERAPY | ONCOLOGY | IMMUNOTHERAPY | TOLERANCE | DEFICIENT | MICE | INDUCTION | RECEPTORS | CANCER | CUTTING EDGE | Antibodies - therapeutic use | Antigens, CD - immunology | Neoplasm Transplantation | Mice, Inbred C57BL | Neoplasms, Experimental - therapy | Programmed Cell Death 1 Receptor - physiology | CD4-Positive T-Lymphocytes - immunology | Drug Synergism | Neoplasms, Experimental - pathology | Animals | Immune Tolerance - immunology | Neoplasms, Experimental - immunology | Cell Line, Tumor | Antigens, CD - physiology | Mice | Programmed Cell Death 1 Receptor - immunology | Tumor Escape - immunology | T cells | LAG-3 | PD-1 | tumor | immunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Abstract LB-251: The checkpoint molecules LAG-3 and PD-1 synergize to maintain tolerance to tumors
by Goldberg, Monica V and Woo, Seng-Ryong and Bankoti, Jaishree and Selby, Mark and Nirschl, Christopher J and Bettini, Matthew L and Vogel, Peter and Grosso, Joseph F and Netto, George and Chaux, Alcides and Smeltzer, Matthew and Workman, Creg J and Pardoll, Drew M and Korman, Alan J and Vignali, Dario AA and Drake, Charles G
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. LB-251 - LB-251
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems
by Grosso, Joseph F and Kelleher, Cristin C and Harris, Timothy J and Maris, Charles H and Hipkiss, Edward L and De Marzo, Angelo and Anders, Robert and Netto, George and Getnet, Derese and Bruno, Tullia C and Goldberg, Monica V and Pardoll, Drew M and Drake, Charles G
Journal of Clinical Investigation, ISSN 0021-9738, 11/2007, Volume 117, Issue 11, pp. 3383 - 3392
Lymphocyte activation gene-3 (LAG-3) is a cell-surface molecule with diverse biologic effects on T cell function. We recently showed that LAG-3 signaling is... 
MEDICINE, RESEARCH & EXPERIMENTAL | MEMORY | PROSTATE-CANCER PATIENTS | ACTIVATION GENE-3 LAG-3 | NEGATIVE REGULATION | CD4(+) T-CELLS | EXPRESSION | CD223 | PD-1 | ANTIGEN | LYMPHOCYTES | T-Lymphocyte Subsets - immunology | CD8-Positive T-Lymphocytes - cytology | Cell Line | Cell Proliferation | Self Tolerance - immunology | T-Lymphocyte Subsets - cytology | Lymphocyte Activation | Humans | Mice, Inbred C57BL | Male | Adoptive Transfer | Antigens, CD - genetics | Antigens, CD - metabolism | Animals | Immune Tolerance - immunology | Mice | CD8-Positive T-Lymphocytes - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
by Grosso, Joseph F and Goldberg, Monica V and Getnet, Derese and Bruno, Tullia C and Yen, Hung-Rong and Pyle, Kristin J and Hipkiss, Edward and Vignali, Dario A. A and Pardoll, Drew M and Drake, Charles G
The Journal of Immunology, ISSN 0022-1767, 06/2009, Volume 182, Issue 11, pp. 6659 - 6669
Lymphocyte Activation Gene-3 (LAG-3) is a transmembrane protein that binds MHC class II, enhances regulatory T cell activity, and negatively regulates cellular... 
LINEAGE RELATIONSHIP | RECEPTOR SIGNALS | MEMORY | GENE-3 LAG-3 | TOLERANCE | EFFECTOR FUNCTION | LIGAND | IMMUNOLOGY | EXPRESSION | CD223 | EXHAUSTION | Antigens, CD - immunology | Antigens, Differentiation - analysis | Cytokines | CD8-Positive T-Lymphocytes - transplantation | Mice, Transgenic | Adoptive Transfer | Antigens, CD - analysis | Signal Transduction - immunology | Lymphocyte Activation - immunology | Animals | Antigens - analysis | Immune Tolerance - immunology | Programmed Cell Death 1 Receptor | Mice | CD8-Positive T-Lymphocytes - immunology | Antigens, Differentiation - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model
by Wada, Satoshi and Yoshimura, Kiyoshi and Hipkiss, Edward L and Harris, Tim J and Yen, Hung-Rong and Goldberg, Monica V and Grosso, Joseph F and Getnet, Derese and Demarzo, Angelo M and Netto, George J and Anders, Robert and Pardoll, Drew M and Drake, Charles G
Cancer Research, ISSN 0008-5472, 05/2009, Volume 69, Issue 10, pp. 4309 - 4318
To study the immune response to prostate cancer, we developed an autochthonous animal model based on the transgenic adenocarcinoma of the mouse prostate... 
EFFECTOR | CD8(+) | ONCOLOGY | IMMUNOTHERAPY | TRANSGENIC MOUSE | TOLERANCE | IN-VIVO | PANCREATIC-CANCER | VACCINE | REGULATORY T-CELLS | ANTIGEN | Immunotherapy - methods | Dendritic Cells - immunology | Male | Mice, Transgenic | Adoptive Transfer | Lymph Nodes - immunology | Cyclophosphamide - therapeutic use | Hemagglutinins - immunology | Prostatic Neoplasms - immunology | T-Lymphocytes, Regulatory - immunology | Animals | Immune Tolerance - immunology | CD8 Antigens - genetics | Mice | CD8-Positive T-Lymphocytes - immunology | Prostatic Neoplasms - drug therapy | Disease Models, Animal | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effect of Depth and Duration of Cooling on Deaths in the NICU Among Neonates With Hypoxic Ischemic Encephalopathy: A Randomized Clinical Trial
by Shankaran, Seetha and Laptook, Abbot R and Pappas, Athina and McDonald, Scott. A and Das, Abhik and Tyson, Jon E and Poindexter, Brenda B and Schibler, Kurt and Bell, Edward F and Heyne, Roy J and Pedroza, Claudia and Bara, Rebecca and Van Meurs, Krisa P and Grisby, Cathy and Petrie Huitema, Carolyn M and Garg, Meena and Ehrenkranz, Richard A and Shepherd, Edward G and Chalak, Lina F and Hamrick, Shannon E. G and Khan, Amir M and Reynolds, Anne Marie and Laughon, Matthew M and Truog, William E and Dysart, Kevin C and Carlo, Waldemar A and Walsh, Michele C and Watterberg, Kristi L and Higgins, Rosemary D and Eunice Kennedy Shriver Natl Inst C and Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
JAMA, ISSN 0098-7484, 12/2014, Volume 312, Issue 24, pp. 2629 - 2639
IMPORTANCE: Hypothermia at 33.5°C for 72 hours for neonatal hypoxic ischemic encephalopathy reduces death or disability to 44% to 55%; longer cooling and... 
WHOLE-BODY HYPOTHERMIA | MEDICINE, GENERAL & INTERNAL | TEMPERATURE | SAFETY | RISK | OUTCOMES | SYSTEMIC HYPOTHERMIA | NEUROPROTECTION | Developmental Disabilities | Hypothermia, Induced - adverse effects | Temperature | Acidosis - etiology | Humans | Infant | Male | Arrhythmias, Cardiac - etiology | Intensive Care Units, Neonatal | Time Factors | Thrombosis - etiology | Hemorrhage - etiology | Survival Analysis | Female | Hypoxia-Ischemia, Brain - therapy | Infant, Newborn | Infants (Newborn) | Care and treatment | Control | Cooling | Neonatal intensive care units | Encephalopathy | Patient outcomes | Infants | Management | Health aspects | Hypothermia | Clinical trials | Intensive care | Neonatal care | Ischemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text A role for the transcription factor Helios in human CD4 +CD25 + regulatory T cells
by Getnet, Derese and Grosso, Joseph F and Goldberg, Monica V and Harris, Timothy J and Yen, Hung-Rong and Bruno, Tullia C and Durham, Nicholas M and Hipkiss, Edward L and Pyle, Kristin J and Wada, Satoshi and Pan, Fan and Pardoll, Drew M and Drake, Charles G
Molecular Immunology, ISSN 0161-5890, 2010, Volume 47, Issue 7, pp. 1595 - 1600
Relative upregulation of the Ikaros family transcription factor Helios in natural regulatory T cells (Tregs) has been reported by several groups. However, a... 
Helios | Regulatory T cells | FoxP3 | TGF-BETA | IKAROS | BIOCHEMISTRY & MOLECULAR BIOLOGY | FACTOR FOXP3 | IMMUNOLOGY | EXPRESSION | Forkhead Transcription Factors - immunology | Cell Line | Promoter Regions, Genetic | RNA, Small Interfering - genetics | Up-Regulation | DNA-Binding Proteins - immunology | CD4-Positive T-Lymphocytes - cytology | Down-Regulation | Humans | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Forkhead Transcription Factors - genetics | CD4-Positive T-Lymphocytes - immunology | Ikaros Transcription Factor - genetics | Animals | Ikaros Transcription Factor - immunology | Mice | Transcription Factors - immunology | Apoptosis | Interleukin-2 Receptor alpha Subunit - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity
by Yen, Hung-Rong and Harris, Timothy J and Wada, Satoshi and Grosso, Joseph F and Getnet, Derese and Goldberg, Monica V and Liang, Kai-Li and Bruno, Tullia C and Pyle, Kristin J and Chan, Siaw-Li and Anders, Robert A and Trimble, Cornelia L and Adler, Adam J and Lin, Tzou-Yien and Pardoll, Drew M and Huang, Ching-Tai and Drake, Charles G
The Journal of Immunology, ISSN 0022-1767, 12/2009, Volume 183, Issue 11, pp. 7161 - 7168
IL-17-secreting CD8 T cells (Tc17) have been described in several settings, but little is known regarding their functional characteristics. While Tc1 cells... 
GROWTH-FACTOR-BETA | TOLERANCE | IN-VIVO | EOMESODERMIN | MICE | DIFFERENTIATION | INDUCTION | IMMUNOLOGY | LINEAGE | TH17 | CUTTING EDGE | T-Lymphocyte Subsets - immunology | CD8-Positive T-Lymphocytes - cytology | T-Lymphocyte Subsets - cytology | Interferon-gamma - secretion | Interleukin-17 - immunology | Adoptive Transfer | Interleukin-17 - biosynthesis | Reverse Transcriptase Polymerase Chain Reaction | Cell Differentiation - immunology | Animals | Flow Cytometry | T-Lymphocyte Subsets - metabolism | Interferon-gamma - immunology | Gene Expression - immunology | CD8-Positive T-Lymphocytes - metabolism | Mice | Mice, Inbred BALB C | STAT3 Transcription Factor - immunology | CD8-Positive T-Lymphocytes - immunology | STAT3 Transcription Factor - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
by Wada, Satoshi and Jackson, Christopher M and Yoshimura, Kiyoshi and Yen, Hung-Rong and Getnet, Derese and Harris, Timothy J and Goldberg, Monica V and Bruno, Tullia C and Grosso, Joseph F and Durham, Nicholas and Netto, George J and Pardoll, Drew M and Drake, Charles G
Journal of Translational Medicine, ISSN 1479-5876, 04/2013, Volume 11, Issue 1, pp. 89 - 89
Background: The FDA recently approved an anti-CTLA-4 antibody (Iplimumab) for the treatment of metastatic melanoma. This decision was based on Phase III... 
CTLA-4 | Lymphocyte | Prostate cancer | Immunotherapy | Treg | MEDICINE, RESEARCH & EXPERIMENTAL | COMBINATION IMMUNOTHERAPY | DOSE-ESCALATION TRIAL | TUMOR-IMMUNITY | EFFECTOR | ANTIGEN 4 CTLA-4 | REGULATORY T-CELLS | INCREASED SURVIVAL | TRANSGENIC MOUSE MODEL | IPILIMUMAB | VACCINES | CD8-Positive T-Lymphocytes - cytology | Immunotherapy - methods | Cell Proliferation | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Humans | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Cyclophosphamide - therapeutic use | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Cancer Vaccines - therapeutic use | Neoplasm Metastasis | Time Factors | Liver Neoplasms - pathology | Mice, Inbred C57BL | Mice, Transgenic | Lung Neoplasms - therapy | Animals | Cell Line, Tumor | Mice | CTLA-4 Antigen - antagonists & inhibitors | Viral antibodies | Antigens | Chemotherapy | Cyclophosphamide | Oncology, Experimental | Melanoma | Antibodies | Research | Drug therapy, Combination | Metastasis | Cancer | Clinical trials | Oncology | Vaccines | FDA approval | Cancer therapies | Medicine | Studies | Lymphocytes | Men | Genetic engineering | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. A role for the transcription factor Helios in human CD4 super(+)CD25 super(+) regulatory T cells
by Getnet, Derese and Grosso, Joseph F and Goldberg, Monica V and Harris, Timothy J and Yen, Hung-Rong and Bruno, Tullia C and Durham, Nicholas M and Hipkiss, Edward L and Pyle, Kristin J and Wada, Satoshi and Pan, Fan and Pardoll, Drew M and Drake, Charles G
Molecular Immunology, ISSN 0161-5890, 04/2010, Volume 47, Issue 7-8, pp. 1595 - 1600
Relative upregulation of the Ikaros family transcription factor Helios in natural regulatory T cells (Tregs) has been reported by several groups. However, a... 
Journal Article
Details down arrow
16. Full Text Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort
by Di Fiore, Juliann M., BSEE and Martin, Richard J., MD and Li, Hong, MS and Morris, Nathan, PhD and Carlo, Waldemar A., MD and Finer, Neil, MD and Walsh, Michele, MD and Eunice Kennedy Shriver Natl Inst and SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health, and Human Development Neonatal Research Network
Journal of Pediatrics, The, ISSN 0022-3476, 2017, Volume 186, pp. 49 - 56.e1
Objective To characterize actual achieved patterns of oxygenation in infants born appropriate vs small for gestational age (SGA) randomized to a lower (85-89%)... 
Pediatrics | hypoxia | intermittent hypoxemia | oxygen saturation | supplemental oxygen | small for gestational age | EPISODES | INTERMITTENT HYPOXEMIA | PREMATURE-INFANTS | FETAL-GROWTH | EXTREMELY PRETERM INFANTS | RESPIRATORY SUPPORT | INDUCED RETINOPATHY | PEDIATRICS | BIRTH | HYPOXIA | SATURATION TARGETS | Continuous Positive Airway Pressure | Humans | Hypoxia - mortality | Male | Survival Rate | Infant, Premature, Diseases - mortality | Infant, Premature, Diseases - therapy | Pulmonary Surfactants - therapeutic use | Hypoxia - therapy | Oxygen Inhalation Therapy | Hypoxia - metabolism | Female | Infant, Extremely Premature | Infant, Premature, Diseases - metabolism | Infant, Small for Gestational Age | Infant, Newborn | Cohort Studies | Surface active agents | Health aspects | Analysis | Mortality | Hypoxia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights